ISB Metabolic Assay Shows Promise in Predicting Treatment Response in Lung Cancer Study Premium The researchers aimed to develop a test that could help clinicians determine whether a patient would respond to therapy, before the onset of treatment. Breaking News AMP Cautions Against Using Cycle Threshold Values for PCR SARS-CoV-2 Tests in Clinical Practice Prevencio, Atlas Genomics to Commercialize Cardiac Blood Tests DiaSorin, Qiagen Obtain CE Mark for Lyme Disease Early Detection Test Sherlock Bio Foundation Licenses CRISPR Tech to Cooper International, United PPE for COVID-19 Tests FDA Grants EUA to Enzo Biochem Sample Collection Kit for COVID-19 Testing Qiagen Nabs CE Mark for High-Throughput SARS-CoV-2 Test Kit
